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Never discourage anyone … who continually makes
progress, no matter how slow. Plato
Many cardiac arrests in hospitalized patients are pre-
ceded by warning signs such as derangements in vital
signs [1–3]. Despite advancements in many aspects of
health care, in-hospital cardiac arrests continue to have
a mortality of approximately 80 % [4]. Efforts to reduce
mortality in hospitalized patients therefore include a
focus on the deteriorating patient in order to provide
earlier treatment and prevent further deterioration and
ultimately cardiac arrest. Serious adverse events (SAEs)
unrelated to the admission diagnosis and due to incor-
rect medical management may occur in up to 17 % of
hospital admissions, and may result in prolonged length
of hospital stay, permanent disability, or even death [5].
The rapid response team (RRT) is tasked with prevent-
ing or responding to SAEs. Two-tiered systems involving
RRTs as distinct from cardiac arrest or “code blue”
teams have been implemented in many hospital settings
in most countries. These systems aim to identify and
manage patients at high risk of further deterioration, al-
tering their trajectory and improving morbidity and
mortality outcomes.
The rapid response system describes the hospital-wide
approach to recognizing and treating deterioration, and
includes an afferent limb (trigger), an efferent limb
(RRT), administration, and governance [6]. Ideally, the
afferent limb and triggering mechanism would identify
only those patients likely to benefit from intervention;
however, no such criteria currently exist. “Crisis detec-
tion” therefore may be from chart-based predefined ob-
servation cutoff points in single or multiple vital signs,
early warning scoring systems, computer algorithm-
based warnings, or clinical concern. The efferent or re-
sponder limb may have various compositions including a
critical care trained nurse and/or doctor, although a
recent meta-analysis found that the presence of a phys-
ician in the rapid response system was not significantly
associated with mortality reduction [7].
While multiple prior single-center studies have shown
a reduction in rates of cardiac arrest, to date there has
been only one large multicenter randomized controlled
trial, the Medical Early Response Intervention and Ther-
apy (MERIT) study, which failed to demonstrate an im-
provement in the Australian setting in cardiac arrest,
unplanned ICU admission, or unexpected death despite
greatly increased emergency team calling [8]. As a con-
sequence of the significant resource requirements to
function effectively, these systems are costly; and despite
more than 27 published studies to date of mostly uncon-
trolled trials of implementation, it remains controversial
whether rapid response systems are effective at prevent-
ing unexpected deaths [9]. Nevertheless, many affluent
nations have begun to introduce these systems.
The Cost and Outcomes of Medical Emergency Teams
(COMET) study [10] evaluated the nationwide imple-
mentation of a rapid response system in the Netherlands
in 2015. This was a pragmatic before-and-after imple-
mentation study involving 12 Dutch hospitals, more
than 160,000 patients, and more than a million inpatient
days, with a significant improvement in the primary
composite endpoint of cardiopulmonary arrests, un-
planned ICU admissions, and all-cause mortality in pa-
tients in general hospital wards.
In the June issue of Critical Care, Brunsveld-Reinders
et al. [11] present the findings of their post-hoc analysis
of the COMET study [10]. Here they have substituted
death without limitation of medical treatment (LOMT)
or “unexpected death” for all-cause mortality, and stud-
ied the proportion of patients dying with a LOMT order
and the timing and prevalence of LOMT with the intro-
duction of a RRT.
Brunsveld-Reinders et al. report that the unadjusted
OR for death without LOMT (“unexpected death”) was
0.557 (95 % CI, 0.40–0.78) while the originally reported
unadjusted OR for all-cause mortality was 0.865 (95 %
CI, 0.77–0.97). Furthermore, in 13 % of patients who
died and for whom a RRT was called, a LOMT was
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instituted or changed after consultation of the RRT. In
this study, 65 % of patients who died had a LOMT
placed at admission while 85 % of patients who died had
some form of LOMT present at the time of death.
Therefore only 15 % died without a LMOT order. There
were no statistically significant differences in the overall
rates of LOMT orders after introduction of the rapid re-
sponse system, and both before and after RRT imple-
mentation the last change to LMOT was in the final few
days of the hospital stay.
There are substantial differences internationally in
withholding or withdrawing life support [12]. Cultural
differences in practices relating to limiting medical treat-
ment will affect interpretation of cardiac arrest data and
overall death rates, because the actions of medical staff
will differ. Hence, it is unclear whether these findings
would be reproducible in other countries with different
practices relating to LOMT. In an analysis of 14,488 pa-
tients from 282 ICUs in seven different geographical re-
gions, deaths occurred after a decision to limit treatment
at varying rates depending on the region [13]. These
ranged from 26 % of ICU patients in Central and South
America compared with 48 % in central and Western
Europe, and there was an even wider variation for indi-
vidual countries. Similarly, in the End-of-Life Practices
in European Intensive Care Units (ETHICUS) study
which assessed ICU end-of-life care in European coun-
tries, the northern European group (Denmark, Finland,
Ireland, the Netherlands, Sweden, and the UK) had more
limitations, less CPR use, and less time until a limitation
of treatment was determined [14]. Withdrawal of life-
sustaining treatments was also more common (47 % vs
18 %, p < 0.001) than in southern Europe (Greece, Israel,
Italy, Portugal, Spain, and Turkey).
While initially intended to prevent cardiac arrests, un-
expected deaths, and unplanned admissions to the ICU,
emerging evidence suggests that RRTs are also used to
review patients who do not have reversible deterioration
and are at the end of life [15]. Brunsveld-Reinders et al.
[11] highlight the impact of RRT in patients where
LOMT has and has not been implemented. Clearly there
is an ongoing need for the intensive care community to
advocate for early discussion about appropriate limita-
tions of therapies and compassionate end of life care
prior to the point of deterioration, while simultaneously
working to achieve better methods of identifying those
patients most likely to benefit from ICU interventions.
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